Agammaglobulinemia type 3, caused by mutations in the CD79A gene, is a rare genetic disorder that affects the immune system. This condition is autosomal recessive, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the disorder. The CD79A gene plays a crucial role in the development and function of B cells, which are a type of white blood cell essential for producing antibodies. When mutations occur in the CD79A gene, it leads to a significant reduction in B cell numbers and, consequently, a severe decrease in antibody production. This article explores the symptoms associated with CD79A gene agammaglobulinemia type 3 and discusses the genetic test available at DNA Labs UAE, which costs 4400 AED.
Symptoms of CD79A Gene Agammaglobulinemia Type 3
Individuals with CD79A gene agammaglobulinemia type 3 typically present symptoms early in life, often within the first few years. The hallmark symptom of this condition is an increased susceptibility to bacterial infections. These infections can be recurrent and severe, affecting various parts of the body, including:
- The respiratory system, leading to conditions such as pneumonia and bronchitis
- The ears, resulting in frequent ear infections (otitis media)
- The skin, causing skin infections
- The gastrointestinal tract, leading to diarrhea and malabsorption issues
Due to the reduced ability to produce antibodies, individuals with this condition may also have difficulty responding to vaccinations and may experience complications from live vaccines. Additionally, some affected individuals may exhibit autoimmune disorders, where the immune system mistakenly attacks the body’s own cells and tissues.
CD79A Gene Agammaglobulinemia Type 3 Autosomal Recessive Genetic Test at DNA Labs UAE
Understanding the genetic basis of CD79A gene agammaglobulinemia type 3 is crucial for accurate diagnosis and management of the condition. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the CD79A gene. This test is an essential tool for confirming the diagnosis, especially in individuals presenting with the symptoms described above.
The cost of the CD79A gene agammaglobulinemia type 3 autosomal recessive genetic test at DNA Labs UAE is 4400 AED. This cost includes the analysis of the CD79A gene to detect mutations that cause the disorder. The test is performed using a blood sample, making it a minimally invasive procedure. Results from the test can provide valuable information for affected individuals and their families, including insights into the risk of passing the condition onto future generations.
For more information about the CD79A gene agammaglobulinemia type 3 autosomal recessive genetic test and to schedule an appointment, please visit DNA Labs UAE.
Conclusion
CD79A gene agammaglobulinemia type 3 is a rare and serious condition that significantly impacts the immune system’s ability to fight infections. Early diagnosis and management are key to improving the quality of life for individuals with this condition. The genetic test offered by DNA Labs UAE provides a critical resource for families seeking answers about this genetic disorder. By identifying mutations in the CD79A gene, affected individuals can receive the appropriate care and support needed to manage their condition effectively.
